Amrad Corp., Collateral Therapeutics, Ludwig Institute for Cancer Research deal

Collateral licensed exclusively the human vascular endothelial growth factor B (VEGF-B) gene from Amrad and the Ludwig Institute. Teams from Amrad and the institute independently identified VEGF-B and cross-licensed patents on the gene. VEGF-B is associated with new blood vessel growth (angiogenesis) in heart and skeletal muscles during embryonic development. ...